Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.152
-0.001 (-0.72%)
Nov 20, 2024, 4:00 PM EST - Market closed
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $5.99 million as of November 21, 2024. Its market cap has decreased by -76.79% in one year.
Market Cap
5.99M
Enterprise Value
253.47K
1-Year Change
-76.79%
Ranking
Category
Stock Price
$0.15
Market Cap Chart
Since September 27, 2005, Viracta Therapeutics's market cap has decreased from $139.50M to $5.99M, a decrease of -95.71%. That is a compound annual growth rate of -15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 6.10M | -72.27% |
| Dec 29, 2023 | 22.00M | -60.57% |
| Dec 30, 2022 | 55.80M | -59.03% |
| Dec 31, 2021 | 136.20M | 278.33% |
| Dec 31, 2020 | 36.00M | -4.26% |
| Dec 31, 2019 | 37.60M | 141.03% |
| Dec 31, 2018 | 15.60M | -87.66% |
| Dec 29, 2017 | 126.40M | 67.20% |
| Dec 30, 2016 | 75.60M | 11.67% |
| Dec 31, 2015 | 67.70M | -57.15% |
| Dec 31, 2014 | 158.00M | -38.26% |
| Dec 31, 2013 | 255.90M | 18.31% |
| Dec 31, 2012 | 216.30M | 295.43% |
| Dec 30, 2011 | 54.70M | -60.48% |
| Dec 31, 2010 | 138.40M | 276.09% |
| Dec 31, 2009 | 36.80M | 234.55% |
| Dec 31, 2008 | 11.00M | -83.89% |
| Dec 31, 2007 | 68.30M | -48.53% |
| Dec 29, 2006 | 132.70M | 24.13% |
| Dec 30, 2005 | 106.90M | -23.37% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 6.30M |
| CNS Pharmaceuticals | 6.29M |
| Alzamend Neuro | 6.27M |
| Cutera | 6.13M |
| NLS Pharmaceutics AG | 6.03M |
| Xenetic Biosciences | 6.01M |
| Biora Therapeutics | 5.99M |
| Ainos | 5.90M |